The ReMission Foundation (formerly known as the BLY Foundation) was established in 2011 with the mission of making a meaningful impact on the fight against cancer by supporting ingenuity in cancer research. With a slogan of "Supporting Promising Cancer Researchers & Lesser-Known Causes," the foundation aims to address the significant challenge posed by cancer, which is the second leading cause of health-related deaths in the United States, with over 1.5 million new cancer cases diagnosed in 2011. The foundation's focus lies in supporting emerging scientific leaders and encouraging them to "think different" and pursue pioneering approaches in cancer diagnosis, treatment, and prevention. By doing so, they aim to accelerate the discovery of a cure and make groundbreaking advancements in the field. While many established scientific minds are already dedicated to the fight against cancer, the ReMission Foundation recognizes the need to fund and fuel research efforts that can lead to transformative breakthroughs. The foundation operates within the Biotechnology and Health Care industries. Although specific headquarters information and recent investment details are currently unavailable, the mission and intent of ReMission Foundation signify its commitment to advancing the fight against cancer by supporting innovative and unconventional approaches to cancer research.
There is no investment information
No recent news or press coverage available for ReMission Foundation.